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journal homepage: www.elsevier .com/ locate / i j idOn September 26, 2018, history will be made. For the ﬁrst
time ever, the United Nations General Assembly will meet in
New York (WHO, 2018a,b) with a speciﬁc focus on tuberculosis
(TB), which is the leading cause of death from an infectious
disease worldwide (WHO, 2017). The theme of the meeting is
‘United to End TB: An Urgent Global Response to a Global
Epidemic’ (United Nations, 2018a). Heads of state will gather in
New York at the ﬁrst-ever United Nations General Assembly
High-Level Meeting on Tuberculosis (UNGA-HLM-TB) to accel-
erate efforts in ending TB and reach all affected people with
prevention and care.
This unprecedented meeting has focused global attention and
generated high expectations of a major ‘step-up’ change for
advancing political will to bring the devastating global TB epidemic
under control. The UNGA-HLM-TB will be attended by heads of
state, government ministers, the UN Secretary General, other UN
leaders, parliamentarians, scientists, healthcare workers, civil
society, community representatives, private sector individuals,
and UN ambassadors, among other advocates (United Nations,
2018b).
The UNGA-HLM-TB will be only the ﬁfth time in the history of
the United Nations that the General Assembly has called for a high-
level meeting devoted to a speciﬁc health issue. The ﬁrst high-level
meeting was the UN Special Session on HIV/AIDS on June 25, 2001
(United Nations, 2018c), the second was on non-communicable
diseases and was held on September 19, 2011 (WHO, 2011), the
third was on Ebola and was held on September 25, 2014 (WHO,
2014), and the fourth was on antimicrobial resistance and was held
on September 21, 2016 (WHO, 2016).
The preparation and organization of the UNGA-HLM-TB has
been a lengthy, coordinated, and consultative process directed by
the President of the UN General Assembly (United Nations, 2017).
Given the complex nature of the factors driving the global TB
epidemic (Grange and Zumla, 1999, 2002; Grange et al., 2001,
2009), discussions have involved multi-stakeholder panels cover-
ing key themes, with numerous consultations and meetings at the
national, regional, and global level and with the participation and
engagement of all stakeholders. Key leadership roles have been
played by The Stop TB Partnership, the World Health Organization
Global TB Programme, the Global TB Caucus of parliamentarians,
and the International Union Against TB and Lung Diseases (The
Union), in liaison with governments of high- and low-incidencehttps://doi.org/10.1016/j.ijid.2018.09.017
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).countries, communities, TB advocacy groups, patients, researchers,
healthcare workers, civil society, specialist organizations, academ-
ics, and industry, among others.
Aligned to this have been calls for urgent and advancing
decisive political action with commitments to end TB. These were
re-iterated at World TB Day 2018, the Moscow Global TB
Ministerial Conference, and the Delhi End TB Summit held earlier
this year (Petersen et al., 2017a,b; Herbert et al., 2018a,b; UK
academics and Professionals to End TB, 2018; Tiberi et al., 2018;
Lienhardt et al., 2018). A civil society hearing (WHO, 2018b) was
held on June 4, 2018 at the United Nations Headquarters, New York,
where discussions focused on four themes: (1) reaching all people
ill and affected by TB; (2) ﬁnancing, (3) innovation, and (4)
partnerships to prioritize communities in an equitable, person-
centered, rights-based response. At that forum, the President of the
General Assembly, HE Mr Miroslav Laj9cák, highlighted the fact that
world leaders had previously committed to end TB, but that
progress was not on track.
Two co-facilitators have been appointed by the UN Secretary
General to lead the inter-governmental consultations and nego-
tiations on the modalities and outcomes of the high-level meeting:
Mr Walton Webson (Permanent Representative of Antigua and
Bermuda) and Mr Koro Bessho (Permanent Representative of
Japan). After difﬁcult negotiations (EATG, 2018) to ﬁnd general
agreement between all UNGA member states, the consensus text of
the political declaration agreed by all UNGA member states was
ﬁnalized by the co-facilitators and released by the President of the
UNGA on September 14, 2018 (United Nations, 2018d).
The 53-point declaration is a formidable and comprehensive
document that captures wide-ranging priorities in which the UN
member states make bold statements (United Nations, 2018d):
(a) Declare their commitment to end the global TB epidemic and
reafﬁrm the 2030 Agenda for Sustainable Development,
including the resolve to end the TB epidemic by 2030;
(b) Pledge to provide leadership and to work together to accelerate
national and global collective actions, investments, and
innovations urgently;
(c) Afﬁrm that TB, including drug-resistant TB, is a critical
challenge being the leading infectious disease cause of death
and the most common form of antimicrobial resistance
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people living with HIV, and that poverty, gender inequality,
vulnerability, discrimination, and marginalization exacerbate
the risks of acquiring TB;
(e) Recognize the devastating impacts of TB, including stigma and
discrimination at all ages, and that TB requires a comprehen-
sive response, including towards achieving universal health
coverage, and one that addresses the social and economic
determinants of the epidemic and that protects and fulﬁls the
human rights and dignity of all people;
(f) Commit to mobilize sufﬁcient and sustainable ﬁnancing with
the aim of increasing overall global investments for ending TB
reaching at least US$ 13 billion a year by 2022;
(g) Commit to mobilize sufﬁcient and sustainable ﬁnancing, to
close the estimated US$ 1.3 billion gap in funding annually for
research;
(h) Ensure that all countries contribute appropriately to research,
effective implementation of recently approved health technol-
ogies, and to strengthen the academic, scientiﬁc, public health,
and laboratory capacity needed to support research and
development for the prevention, diagnosis, treatment and
care, inter alia through the engagement of domestic, interna-
tional, and innovative ﬁnancing mechanisms.
Whilst all governments are expected to fully commit them-
selves to adopting and implementing the goals and targets that will
be set in the declarations, the most difﬁcult issue and the hardest
aspect will be to get member states to deliver on their commit-
ments. There have been many political declarations on TB and
other killer infectious diseases over the past decade in which UN
members states have willingly adopted UNGA resolutions such as
the Sustainable Development Goals of Agenda 2030, committing to
implementation of the goals by 2030. However, leaders of many
high TB endemic countries have not lived up to these commit-
ments. TB remains a low domestic priority health agenda in many
countries, with no clear intention of sustainability (Raviglione
et al., 2012; Petersen, 2017b; Zumla et al., 2016).
Thus a critical feature of the declaration (United Nations, 2018d)
is that member states will request that the Director-General of the
World Health Organization continues to develop the multisectoral
accountability framework in line with World Health Assembly
Resolution 71.3 and ensure its timely implementation no later than
2019. They are also expected to request that the Secretary-General,
in close collaboration with the Director-General of the World
Health Organization, promotes collaboration among all stake-
holders to end the TB epidemic and implement the UNGA-HLM-TB
declaration. A progress report in 2020 is expected on global and
national progress in achieving the agreed goals, to inform
preparations for a comprehensive review by heads of state and
government at a high-level meeting in 2023. This could be made
forthcoming by identifying ‘facilitators’ or ‘monitors’, such as the
Stop TB Partnership (Stop TB Partnership, 2018), the Global TB
Caucus of parliamentarians (Global TB Caucus, 2018), and the
International Union Against TB and Lung Disease (The Union, 2018)
to make governments accountable and translate these very
laudable political declarations into concerted action with strong
commitment from both high- and low-TB burden countries.
The UNGA-HLM-TB meeting on September 26, 2018 will be the
most signiﬁcant political meeting ever to be held on TB. It has
generated the long-awaited ‘unity of purpose’ between the main
lead organizations and stakeholders involved in global TB control
and has enthused and excited the global TB fraternity. The real
challenge will be translating the ‘hype’ and ‘hope’ of political
declarations into ‘reality’ by getting governments to commit to the
UNGA-HLM-TB declarations and deliver and sustain resources. This
will be key to ending the TB epidemic and also requires the entireTB community and those organizations leading the global TB
control effort to align their common vision and unite to work
together, exploring synergies and achieving an enhancing effect.
Currently, the global TB community has the knowledge, expertise,
and tools required to achieve global control.
The UNGA-HLM-TB brings renewed hope and increased
prospects of much-needed increased funding and the political
commitment required to control TB and achieve the World Health
Organization and Stop TB Partnership ‘End TB targets’ for 2030.
With the UNGA-HLM-TB declarations and unprecedented com-
mitment of the UN member states, the year 2018 will mark a
critical turning point in the global ﬁght against TB. If all member
states sincerely deliver on their commitments, the world’s number
one cause of death from an infectious disease will be conﬁned to
the history books in the next few decades. Only time will tell.
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